Composition for treating infantile eczema, preparation, preparation method of preparation, and application of composition

Abstract

The invention discloses a composition for treating infantile eczema, a preparation, a preparation method of the preparation, and an application of the pcomposition. The preparation comprises an activeingredient D, a component A, a component B and component C; the active ingredient D comprises, by weight, 1 part of a pitera fermentation product filtrate and 0.45 part of plant extract; and the component A comprises 0.06 part of EDTA-2Na, 3 parts of glycerin, 2 parts of butanediol, 0.03 part of xanthan gum, 0.02 part of low acyl gellan gum, 0.02 part of high acyl gellan gum and 90 parts of water. The piter fermentation product is combined with traditional Chinese medicine components having the efficacy of clearing heat and drying dampness to uniformly act on the eczema part of skins in orderto make the skins fully absorb medicines, so local vasoconstriction, congestion reduction and inflammation reduction are achieved, thereby symptoms of eczema are treated or alleviated.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a composition for treating infantile eczema, a preparation, a preparation method and application. Background technique [0002] Infant eczema is a common and frequently-occurring disease in dermatology. The motherland medicine calls it "milk ringworm" or "fetal sore". In recent years, it is believed that this disease is the infantile type of atopic dermatitis. It is a skin inflammation with obvious exudation tendency caused by various internal and external factors. According to the performance of skin lesions, eczema can be divided into three types: acute, subacute, and chronic. In mild cases, local erythema, papules, and secretions ooze out of the skin; in severe cases, erosion and itching are the main recurrent attacks, which cannot be cured for a long time, seriously affecting the health and normal development of infants and young children. [0003] At present, corticostero...

AI Technical Summary

Problems solved by technology

[0003] At present, corticosteroid hormones and their compound preparations with antibacterial drugs are mostly used clinically to treat infantile eczema, but long-term use can cause dependence and various adverse reactions, such as skin atrophy, telangiectasia, pigmentation, etc.

Moreover, since the skin of infants and young children is thin and tender, and their body surface area is relatively large, the percutaneous absorption of drugs is more than that of adults. Inhibition of the thalamic-pituitary-adrenal axis, even with weak corticosteroids, long-term use can cause growth arrest

Images